Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06521502 · ClinicalTrials.gov registry record
The APS Phenotyping Study
A clinical trial of Sepsis and Pneumonia, sponsored by Vanderbilt University Medical Center.
- Recruiting
- Registry status
- 4,000
- Enrollment target
- 20
- Study locations
NCT06521502 is a study of Sepsis and Pneumonia that is actively recruiting participants, run by Vanderbilt University Medical Center. The registered enrollment target is 4,000 participants, below the 6,520-participant average among 90 other Sepsis trials with a reported enrollment target (39% lower). The trial reports 20 study locations across 11 states.
The verdict
NCT06521502, a study of Sepsis and Pneumonia, is actively recruiting participants, sponsored by Vanderbilt University Medical Center.
- RECRUITING
- Registry status
- 4,000 participants
- Enrollment target
- 20
- Study locations
Study Summary
The goal of the observational APS phenotyping study is to better understand risk factors, potential biomarkers, length and severity of illness, and recovery for adults with ARDS, pneumonia, and/ or sepsis. This study will also generate a biobank of specimens collected from these patients that will be available to investigators for future studies of ARDS, sepsis, and/or pneumonia.
Interventions
- OTHER Blood collection
- OTHER Urine Collection
- OTHER Nasal, oral, and rectal swabs
- OTHER Stool collection
- OTHER Heat Moisture Exchange Filter collection
Study Locations (20)
California
- Fresno Community Hospital and Medical Center - Fresno
- Stanford University - Palo Alto
- San Francisco General Hospital - San Francisco
- University of California, San Francisco - San Francisco
Colorado
- University of Colorado, Denver - Denver
- Denver Health and Hospital Authority - Denver
- National Jewish Health - Denver
- UC Health Medical Center of the Rockies - Loveland
Illinois
- Northwestern Memorial Hospital - Chicago
- University of Chicago - Chicago
Tennessee
- Meharry Medical College - Nashville
- Vanderbilt University Medical Center - Nashville
Utah
- Intermountain Medical Center - Murray
- University of Utah - Salt Lake City
Maryland
- Johns Hopkins Univeristy - Baltimore
Michigan
- University of Michigan - Ann Arbor
Missouri
- Washington University School of Medicine - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,000 participants |
| Start Date | 2024-07-25 |
| Est. Completion | 2029-04-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06521502
The ClinicalTrials.gov registry entry for NCT06521502 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 4,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 6,520-participant average among 90 other Sepsis trials with a reported enrollment target (39% lower). The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Sepsis appearing as the primary indexed condition, and to 5 interventions - of which Blood collection is the first listed.
NCT06521502 reports 20 study locations spanning 11 distinct geographic areas - top geographies include California, Colorado, Illinois.
Frequently Asked Questions
What is clinical trial NCT06521502 about?
NCT06521502 is a clinical study titled "The APS Phenotyping Study". The goal of the observational APS phenotyping study is to better understand risk factors, potential biomarkers, length and severity of illness, and recovery for adults with ARDS, pneumonia, and/ or sepsis. This study will also generate a biobank of specimens collected from these patients that will b...
What is the current status of trial NCT06521502?
This trial is currently recruiting. The enrollment target is 4,000 participants. The study started on 2024-07-25. Estimated completion is 2029-04-30.
What conditions does trial NCT06521502 study?
This clinical trial studies the following conditions: Sepsis, Pneumonia, ARDS.
What interventions are being tested in trial NCT06521502?
The interventions under investigation include: Blood collection (OTHER), Urine Collection (OTHER), Nasal, oral, and rectal swabs (OTHER), Stool collection (OTHER), Heat Moisture Exchange Filter collection (OTHER).
Who is sponsoring clinical trial NCT06521502?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06521502 being conducted?
This trial has 20 study locations across California, Colorado, Illinois, Maryland, Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sepsis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Senolytics To slOw Progression of Sepsis (STOP-Sepsis) Trial
RECRUITING · Phase 2
-
Early Versus Late Adjunctive Vasopressin in Septic Shock
RECRUITING · Phase 4
-
Renin Angiotensin Aldosterone System In Septic Kids
RECRUITING
-
The RightCall: Implementing a Sepsis Diagnostic Toolkit to Improve Pediatric Diagnosis in ED Transfer Calls
RECRUITING · NA
-
External Drainage of Thoracic Duct Lymph to Reduce Inflammatory Cytokines in Septic Shock Patients
RECRUITING · NA
-
Limited Versus Extended Trophic Feeding (LET-FEED) Trial
RECRUITING · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.